ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,645.35
0.25%
US Tech 100
19,764.40
-0.41%
다우존스 지수
40,795.03
1.45%
Bitcoin
64,481.26
-0.56%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) 뉴스

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVDL
일자시간출처헤드라인심볼기업
2023/08/0405:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0405:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0405:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0405:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0405:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0405:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0405:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/08/0221:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/07/2105:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/07/0705:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/2404:05Dow Jones NewsAvadel Pharmaceuticals to Intervene in Jazz Pharmaceuticals Lawsuit Over FDA RulingNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/2401:12Dow Jones NewsAvadel ADRs Tumble 14% Following Lawsuit Trying to Overturn FDA Approval of Similar DrugNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/2307:59Dow Jones NewsJazz Pharmaceuticals Files Complaint Against FDA for Decision on Avadel Pharmaceuticals' LumryzNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/2221:00GlobeNewswire Inc.Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIIINASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/1421:00GlobeNewswire Inc.Avadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundation’s 2023 Young Investigators Research ForumNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/1321:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for NarcolepsyNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0705:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0605:07Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0520:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0520:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ™ (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Adults Living with NarcolepsyNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0121:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Jefferies Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0105:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/06/0105:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ at SLEEP 2023NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/05/1105:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/05/0505:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/05/0505:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/05/0505:05GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/05/0405:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/05/0207:50Dow Jones NewsADRs End Lower; Avadel Pharmaceuticals Gets Boost From FDANASDAQ:AVDLAvadel Pharmaceuticals PLC
 검색 관련기사 보기:NASDAQ:AVDL

최근 히스토리

CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
NYSE
VZ
Verizon Communications
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
CCOM
SILVER
SILVER
USOTC
BASFY
BASF (QX)
FX
USDJPY
US Dollar vs Yen
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유